AAAAAA

   
Results: 1-7 |
Results: 7
Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma
Authors: Lillington, DM Micallef, INM Carpenter, E Neat, MJ Amess, JAL Matthews, J Foot, NJ Young, BD Lister, TA Rohatiner, AZS
Citation: Dm. Lillington et al., Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma, J CL ONCOL, 19(9), 2001, pp. 2472-2481
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis
Authors: Foran, JM Norton, AJ Micallef, INM Taussig, DC Amess, JAL Rohatiner, AZS Lister, TA
Citation: Jm. Foran et al., Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis, BR J HAEM, 114(4), 2001, pp. 881-883
Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia
Authors: Micallef, INM Rohatiner, AZS Carter, M Boyle, M Slater, S Amess, JAL Lister, TA
Citation: Inm. Micallef et al., Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia, BR J HAEM, 113(2), 2001, pp. 443-445
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia
Authors: Rohatiner, AZS Bassan, R Raimondi, R Amess, JAL Arnott, S Personen, A Rodeghiero, F Barbui, T Bradburn, MJ Carter, M Lister, TA
Citation: Azs. Rohatiner et al., High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia, ANN ONCOL, 11(8), 2000, pp. 1007-1015
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell supportfor lymphoid malignancies
Authors: Micallef, INM Lillington, DM Apostolidis, J Amess, JAL Neat, M Matthews, J Clark, T Foran, JM Salam, A Lister, TA Rohatiner, AZS
Citation: Inm. Micallef et al., Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell supportfor lymphoid malignancies, J CL ONCOL, 18(5), 2000, pp. 947-955
High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up
Authors: Apostolidis, J Gupta, RK Grenzelias, D Johnson, PWM Pappa, VI Summers, KE Salam, A Adams, K Norton, AJ Amess, JAL Matthews, J Bradburn, M Lister, TA Rohatiner, AZS
Citation: J. Apostolidis et al., High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up, J CL ONCOL, 18(3), 2000, pp. 527-536
Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996
Authors: Papamichael, D Norton, AJ Foran, JM Mulatero, C Mathews, J Amess, JAL Bradburn, M Lister, TA Rohatiner, AZS
Citation: D. Papamichael et al., Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996, J CL ONCOL, 17(9), 1999, pp. 2847-2853
Risultati: 1-7 |